The US Food and Drug Administration expects to inspect Boston Scientific factory in the “near future” as part of its probe into the company’s coronary stent recall, the Wall Street Journal reported.

US Food and Drug Administration expects to inspect Boston Scientific factory in the “near future” as part of its probe into the company’s coronary stent recall, the Wall Street Journal reported.